研究実績

A Multicenter Phase II Trial of Ramucirumab Plus Irinotecan in Patients with Early Relapsed Gastric Cancer During or After Adjuvant Docetaxel Plus S-1 Therapy: RAMIEL Trial (OGSG1901)

Atsushi Takeno, Toshifumi Yamaguchi, Yusuke Akamaru, Hidekazu Hirano, Masaaki Motoori, Yoshihiro Kakeji, Yosuke Kito, Takashi Nomura, Takeshi Kawakami, Masahiro Tanemura, Hiroyuki Okuda, Tomohiro Matsushima, Toshio Shimokawa, Yukinori Kurokawa, Shunji Endo, Narikazu Boku and Taroh Satoh

ASCO-GI 2026, San Francisco, California, United States 8-10 Jan2026

前の記事 次の記事 一覧ページへ戻る